Effect of pippali Modaka in management of anaemia.

A Pharmaceutico Analytical Study of Pippali Modaka and Its Clinical effect on Pandu. - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/05/067604

Enrollment

Registered

2024-05-17

Start date

Unknown

Completion date

Unknown

Last updated

2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Hb gm% within the range 8-11 gm/dl Age 20-60 yrs Both male and female patients Iron deficiency anaemia -mild and moderate cases

Exclusion criteria

Exclusion criteria: Hb gm% below8gm/dl Haemolytic and aplastic anaemia Peptic Ulcer Degenerating diseases Tuberculosis Hypertension Cardiac Pathology Anaemia due to malignancy Below 20 yrs of age

Design outcomes

Primary

Measure	Time frame
Relief in weakness fatigueness dizzinessTimepoint: 30 days for both A & B groups	—

Secondary

Measure	Time frame
Hb level increasesTimepoint: 30 days for both A & B groups	—

Countries

India

Contacts

Public ContactProf Dr Rajib Kishore Jena

Gopabandhu Ayurveda Mahavidyalaya,Puri

rajibjena89@gmail.com8260540055

Outcome results